Lobbying organisation

Boehringer Ingelheim Canada Ltd.

29 meetings with public office holders, Aug 25, 2025 to Jul 15, 2026.

61 meetings on record since 2022, their first on record.

Meetings over time

  • Aug 2025: 3 meetings, with Max Lee
  • Sep 2025: 8 meetings, with Daniel MacDonald, Luke Carter, Russell Vallee, Mike Poitras, elisha hurlock
  • Oct 2025: 1 meeting, with Ritu Banerjee, Rodrigo Arancibia
  • Nov 2025: 3 meetings, with Shahad Khalladi, Shadad Khallidi
  • Dec 2025: 1 meeting, with Miro Froehlich, Nasser Haidar, Galen Richardson, Peter M. Boehm, Martin Moen
  • Jan 2026: 2 meetings, with Ritu Banerjee, Jocelyn Milburn, Justine Frame
  • Feb 2026: 0 meetings
  • Mar 2026: 2 meetings, with Maggie Chi, Justine Frame, Jibril Hussein, nora draper
  • Apr 2026: 1 meeting, with Ritu Banerjee, Jocelyn Milburn
  • May 2026: 0 meetings
  • Jun 2026: 6 meetings, with Mackenzy Metcalfe, Dan Mazier, Maggie Chi
  • Jul 2026: 2 meetings, with Raquel Dancho
Aug 2025peak 8 in a monthJul 2026

Hover or focus a month to see who was met.

What they lobby about

The registry's own subject categories, chosen by the lobbyist on each filing. Each one opens its own page.

Who they met

Conservative2 met · 4 meetings
Liberal2 met · 3 meetings
Not in Arena's member list33 met · 58 meetings
  • Justine Frame
  • Luke Carter
  • Ritu Banerjee
  • Daniel MacDonald
  • Mackenzy Metcalfe
  • Manuela Tomic
  • Max Lee
  • Russell Vallee
  • Elisha Hurlock
  • Jibril Hussein
  • Jocelyn Milburn
  • Mike Poitras
  • Mike Poitras
  • Shahad Khalladi
  • Annahat Kochhar
  • Chase Knight
  • elisha hurlock
  • Elizabeth Wong
  • Galen Richardson
  • Greg Orencsak
  • Hosai Zurmati Halim
  • Lisa Xie
  • Martin Moen
  • Miro Froehlich
  • Nasser Haidar
  • nora draper
  • Pamela Aung-Thin
  • Peter M. Boehm
  • Rodrigo Arancibia
  • Sandenga Yeba
  • sarah Lawley
  • Shadad Khallidi
  • victoria morton

Health Canada (HC) (30) · Innovation, Science and Economic Development Canada (ISED) (12) · House of Commons (8) · Public Health Agency of Canada (PHAC) (4) · Finance Canada (FIN) (3) · Treasury Board Of Canada Secretariat (TBS) (3)

In their own words

  • Arranging meetings for the client to brief government officials on the business of Boehringer Ingelheim Canada Ltd.
  • Pharmaceutical pricing policy arising from the jurisdiction of the patented medicine prices review board (PMPRB).
  • Arranging meetings to brief government officials on the business of Boehringer Ingelheim Canada Ltd.

Meetings from the Commissioner of Lobbying of Canada. Canada does not require lobbyists to disclose what they spend, so there is no lobbying budget to report here — only the meetings they filed.